IOVA — Iovance Biotherapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Iovance Biotherapeutics Inc (IOVA), worth $4.03M combined. Over the quarter 2 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| QVT | $2.82M | 0.18% | NO CHANGE |
| Quadrature | $1.16M | 0.00% | +75.5% |
| IMC | $54.91K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.